Marc A. Cohen, MD, MPH

The diseases I treat as part of the multidisciplinary skull base tumor team include skull base tumors such as sinus cancers, pituitary adenomas (tumors of the pituitary gland), meningiomas and craniopharyngiomas (brain tumors), and chordomas (tumors of the bones of the skull and spine). In addition, I treat patients with head and neck and thyroid cancer. As part of the MSK team, I work to use minimally invasive surgical techniques whenever possible.

When surgery is necessary, I work with neurosurgeons and fellow head and neck surgeons to remove tumors and to minimize damage to normal tissue. This helps us limit unwanted side effects of cancer treatment.

My research focuses on patients’ outcomes after treatment for head and neck and skull base tumors. I am specifically interested in studying quality of life following minimally invasive and endoscopic surgeries. I believe we need to focus on cancer treatments that offer the potential for the fewest possible side effects.

Having gone through significant medical challenges with my own family, I understand the importance of considering all aspects of a cancer diagnosis. Providers need to be sensitive to every issue that impacts patients. I hope that my patients see me as someone who cares about them and their families as people.